As of 2025-07-03, the Intrinsic Value of Oncolytics Biotech Inc (ONC.TO) is -1.77 CAD. This ONC.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.04 CAD, the upside of Oncolytics Biotech Inc is -270.52%.
Based on its market price of 1.04 CAD and our intrinsic valuation, Oncolytics Biotech Inc (ONC.TO) is overvalued by 270.52%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.77 - -1.77 | -1.77 | -270.52% |
| P/E | (0.08) - (0.18) | (0.13) | -112.8% |
| DDM - Stable | (3.25) - (10.23) | (6.74) | -748.0% |
| DDM - Multi | (0.24) - (0.57) | (0.33) | -132.1% |
| Market Cap (mil) | 92.37 |
| Beta | 0.99 |
| Outstanding shares (mil) | 88.82 |
| Enterprise Value (mil) | 90.66 |
| Market risk premium | 5.10% |
| Cost of Equity | 9.38% |
| Cost of Debt | 5.00% |
| WACC | 9.33% |